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SUMMARY
Sorting of endocytic ligands and receptors is critical for diverse cellular processes. The
physiological significance of endosomal sorting proteins in vertebrates, however, remains largely
unknown. Here we report that sorting nexin 3 (Snx3) facilitates the recycling of transferrin
receptor (Tfrc), and thus is required for the proper delivery of iron to erythroid progenitors. Snx3
is highly expressed in vertebrate hematopoietic tissues. Silencing of Snx3 results in anemia and
hemoglobin defects in vertebrates due to impaired transferrin (Tf)-mediated iron uptake and its
accumulation in early endosomes. This impaired iron assimilation can be complemented with non-
Tf iron chelates. We show that Snx3 and Vps35, a component of the retromer, interact with Tfrc to
sort it to the recycling endosomes. Our findings uncover a role of Snx3 in regulating Tfrc
recycling, iron homeostasis, and erythropoiesis. Thus, the identification of Snx3 provides a genetic
tool for exploring erythropoiesis and disorders of iron metabolism.
INTRODUCTION
Iron is an essential cofactor in diverse biological processes such as oxygen transport,
electron transport, signal transduction, and DNA synthesis. In mammals, extraintestinal cells
such as developing erythrocytes primarily depend on the transferrin (Tf) cycle to acquire
iron from the circulation (Andrews, 2008; Hentze et al., 2004; Levy et al., 1999). Each Tf
can bind two ferric iron (Fe3+) molecules. The diferric Tf may interact with transferrin
receptor (Tfrc) on the cell surface, followed by internalization through clathrin-mediated
endocytosis. During the acidification and maturation of endosomes, iron is reduced by six-
transmembrane epithelial antigen of the prostate member 3 (Steap3) and subsequently
exported out of endosomes by divalent metal transporter 1 (Fleming et al., 1998; Gunshin et
al., 1997; Ohgami et al., 2005). This iron may either be delivered to the cytoplasmic iron
storage protein ferritin or iron-containing enzymes by poly (rC) binding proteins (Nandal et
al., 2011; Shi et al., 2008), or be imported into the mitochondria for the synthesis of heme
and iron sulfur clusters by mitoferrin 1 (Mfrn1, Slc25a37) and its partner Abcb10 in
developing erythroblasts (Chen et al., 2009; Shaw et al., 2006). The rest of the Tf complex,
apo-Tf and Tfrc, are sorted into the recycling endosomes and returned to the cell surface.
The Tf cycle involves three major processes in Tf-Tfrc trafficking: internalization into early
endosomes, sorting into recycling endosomes, and recycling to the cell surface (Chen and
Paw, 2012; Schultz et al., 2010). Each of these unidirectional movements is likely to be
mediated by specific trafficking machinery. The final step, the trafficking of Tfrc from
recycling endosomes to the cell surface, has previously been shown to be mediated by
Sec15l1, as its mutation causes anemia in the hemoglobin deficit (hbd) mouse (Lim et al.,
2005; White et al., 2005; Zhang et al., 2006). The sorting mechanisms responsible for earlier
trafficking events in the Tf cycle, however, remain poorly understood.
Sorting nexins (Snxs) are a family of phosphoinositide-binding proteins that play critical
roles in many cellular pathways including nutrient uptake, signal transduction, and
development (Cullen and Korswagen, 2012; Johannes and Popoff, 2008). They are essential
components of retromer complexes that regulate the retrograde protein transport through
early endosomes. The classical retromer complex is composed of the cargo-selective
component, Vps26-Vps29-Vps35, and a heterodimeric coat formed by Snx1, Snx2, Snx5,
and Snx6 (Cullen and Korswagen, 2012; Johannes and Popoff, 2008; Johannes and Wunder,
2011). Besides these four sorting nexin members, mammals have 29 additional Snxs
(Cullen, 2008). These Snxs may have evolved more specialized functions and may regulate
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retrograde trafficking in tissue-specific or cargo-selective manners. In vitro cell biological
studies have implicated several Snxs, including Snx4, Snx9, Snx15, and Snx18, in regulating
Tf uptake and Tfrc internalization (Barr et al., 2000; Park et al., 2010; Traer et al., 2007);
however, direct evidence is lacking regarding the functional significance of these molecules
in mammalian iron physiology.
From an mRNA sequencing experiment, we found that Snx3 is highly expressed in
developing red cells and hematopoietic tissues. Given the intriguing role of the Snx family
members in intracellular trafficking along with the strong induction of Snx3 during erythroid
maturation, we hypothesized a functional role for Snx3 in Tf-mediated iron metabolism. To
dissect the biochemical function of Snx3 in red cell development, we utilized loss-of-
function studies in zebrafish embryos and mammalian erythroid cells. Our complementary
results from genetic, biochemical, and biological studies consistently show that Snx3
regulates Tfrc trafficking and is essential for maintaining vertebrate iron homeostasis.
RESULTS
Snx3 is highly expressed in erythroid tissues
Since maturing erythroblasts consume a large amount of iron for the production of heme and
hemoglobin (Andrews, 2008; Richardson et al., 2010), it is likely that the sorting molecules
responsible for Tf-mediated iron uptake would be abundantly expressed in erythroid tissues.
To identify candidate trafficking genes involved in erythropoiesis, we analyzed gene
expression profiles during red cell differentiation from an mRNA sequencing (RNA-seq)
experiment (Wong et al., 2011). Cells from mouse fetal liver, an organ for definitive
erythropoiesis, were sorted by flow cytometry into five distinct sub-populations (R1 to R5),
reflecting progressive stages of erythroid maturation (Zhang et al., 2003). We found that the
expression of an endosomal sorting molecule, Snx3, was up-regulated >3.5 fold in all later
stages of differentiating erythroblasts relative to primitive progenitor cells (Figure 1A). The
expression profile of Snx3 is similar to that of Tfrc and heme synthesis genes such as
ferrochelatase (Fech), suggesting that they may have coordinated functions. In contrast, no
substantial changes in the expression were observed for the genes encoding classical
retromer components (Table S1). In worms and flies, SNX3 has been shown to control Wnt
signaling by regulating the retromer-dependent transport of Wntless, a membrane protein
required for Wnt secretion (Harterink et al., 2011; Zhang et al., 2011). Cell biological
studies in human epidermoid carcinoma cells suggest that SNX3 controls endosomal
morphology and endocytic cargo transport (Xu et al., 2001). However, the role of Snx3 in
iron homeostasis and vertebrate erythropoiesis is unknown.
To confirm the enriched expression of Snx3 and thus its potential function in hematopoietic
tissues, we examined the expression pattern of Snx3 in developing mouse embryos.
Consistent with the RNA-seq data, Snx3 was highly expressed in mouse primitive (yolk sac
at E8.5) and definitive hematopoietic tissues (fetal liver at E12.5 and E15.5, Figure 1B). The
specificity of Snx3 signal was confirmed by using a negative control gene, which displayed
no staining in the bloods islands of mouse embryos (Figure S1). At E15.5, Snx3 was also
expressed in heart, lung, kidney, and gut, suggesting that it may play a role, in either iron
metabolism or Wnt signaling, in these tissues. To further interrogate the erythroid
enrichment profile of Snx3, we chemically differentiated mouse Friend erythroleukemia
(MEL) cells with dimethyl sulfoxide (DMSO), and analyzed their protein levels by western
analysis. We found that Snx3,as well as the erythroid proteins, Tfrc and Fech,were induced
during MEL cell differentiation (Figures 1C and 1D ). The expression pattern of Snx3
closely resembled that of Tfrc. Both proteins displayed increased abundance in the first 4
days and a moderate reduction at day 5, whereas evident up-regulation for Fech was
observed between day 3 and day 5 after chemical differentiation, consistent with the
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phenomenon that iron acquisition precedes heme synthesis (Figures 1C and 1D). In contrast
to Snx3 and other erythroid genes, Snx4, a sorting nexin previously implicated in Tfrc
trafficking (Traer et al., 2007), did not show differential expression during erythroid
maturation (Figures 1A, 1C, and 1D). This indicates that although Snx4 was shown to
regulate endosomal sorting of Tfrc in HeLa cells (Traer et al., 2007), it may not be the
primary sorting molecule that regulates Tf-mediated iron uptake in red cells.
To further examine whether the erythroid expression of Snx3 is conserved among higher
vertebrates, we performed whole mount in situ hybridization (WISH) analysis on zebrafish
embryos. We detected robust expression of snx3 in the intermediate cell mass (ICM), the
functional equivalent tissue of the yolk sac blood islands in mammals, in a pattern similar to
the erythroid transcription factor gata1 (Figure 2A). The ICM expression for snx3 was
further verified using cloche, a mutant lacking hematopoietic stem cells and vascular
progenitors (Stainier et al., 1995), and dino, a mutant with expanded blood due to its
ventralized phenotype (Hammerschmidt et al., 1996). Similar to the erythroid markers tfr1a
and gata1, zygotic expression of snx3 was first detected in the ICM between 10 and 15-
somite stages in zebrafish embryos (Figure S2A). Taken together, our data consistently
show that the expression of Snx3 is enriched in erythroid tissues of higher vertebrates.
Morpholino knockdown of snx3 produces anemia in zebrafish
To elucidate the role of Snx3 in erythropoiesis, we knocked down snx3 in zebrafish embryos
with a translation-blocking morpholino and a pre-mRNA splice-blocking morpholino
(Figure S2B). Results from reverse transcription PCR (RT-PCR) validated that the injection
of the splice-blocking morpholino interfered with the splicing of snx3 pre-mRNA (Figure
S2C). Western analysis revealed that both morpholinos specifically reduced the expression
of snx3, while the controls, snx4 and α-actin, were unaffected (Figure 2B). Knockdown of
snx3 in zebrafish embryos resulted in a profound anemia, as indicated by the absence of o-
dianisidine positive hemoglobinized cells, at both 48 and 72 hours post fertilization (hpf)
(Figure 2C). To determine whether the anemic phenotype was due to impaired heme
production or a defect in hematopoiesis, we examined the expression of an erythroid
progenitor marker (gata1), a terminal erythroid marker (βe1 globin), and a myeloid lineage
marker (myeloperoxidase, mpo). The expression of both gata1 and mpo was normal in snx3-
deficient embryos (Figure S2D), indicating that neither erythroid nor myeloid specification
was affected. We detected robust expression of βe1 globin in snx3-morphant embryos at 48
hpf despite the absence of heme staining (Figures 2C and S2E), suggesting that these globin-
expressing erythrocytes are hypochromic. The morphant embryos, however, exhibited
substantial decreases in the red cell numbers at 72 hpf (Figure S2E). We confirmed the
reduction in erythrocyte number by silencing snx3 in a Tg(globin-LCR:eGFP) transgenic
line, which expresses gfp under the globin locus control region (LCR) enhancer (Ganis et
al., 2012). Quantification by flow cytometry revealed a significant reduction in erythrocytes
at 72 hpf, while no change in erythroid cell number was observed at 48 hpf (Figure 2D),
confirming the hypochromic anemia at 48 hpf. The decrease in erythroid cell number at the
later stage is likely an outcome of apoptosis due to severe iron deficiency. A similar trend in
the expression of βe1 globin has been observed in the zebrafish mutant chianti, which has a
tfr1a defect (Wingert et al., 2004). These results indicate that snx3 is required for
hemoglobin synthesis in the erythroid tissues of teleosts.
Silencing of Snx3 results in hemoglobinization defects in mouse hematopoietic cells
To analyze whether Snx3 has a conserved role in mammalian red cell development, we
silenced Snx3 in mouse primary fetal liver (MPFL) cells using shRNA hairpins (Figure 3A).
Consistent with the results in zebrafish, retroviral infection of Snx3 shRNAs resulted in
>75% reduction in total hemoglobin content (Figure 3B). To further understand the
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erythroid function of Snx3, we generated two stable MEL cell clones expressing Snx3-
shRNAs. Under both undifferentiated and chemically differentiated conditions, Snx3
expression was efficiently silenced (Figure 3C). The expression of Snx4 was not affected,
validating the specificity of the targeted knockdown by the shRNAs. Results from o-
dianisidine staining revealed severe defects of hemoglobin production in these Snx3-
silenced MEL cells (Figures 3D and 3E).
Snx3 is required for cellular iron uptake through regulating the trafficking of Tf-Tfrc
complex
To determine whether the hemoglobinization defect observed in Snx3-deficient cells is due
to impaired uptake and delivery of Tf-bound iron, we labeled the stable shRNA MEL clones
with 59Fe-saturated Tf. We found a reduction in Tf uptake, iron delivery, as well as iron
incorporation into heme in Snx3-silenced cells (Figure 4A). Interestingly, these cells have
normal activities of iron-containing enzymes such as cytosolic xanthine oxidase and
mitochondrial aconitase (Figures S3A and S3B). It is likely that the differentiating erythroid
cells may prioritize their limited iron supplies to first fulfill the requirement for the basic
cellular processes. In addition, the demand of iron by these processes is much lower than the
requirement of iron for heme synthesis in differentiating erythroid cells. When cellular iron
is limited, the enzymes involved in basic metabolism such as xanthine oxidase and aconitase
may still acquire sufficient amount of iron while less iron is provided for heme production.
To examine whether the reduced iron uptake is due to defective endosomal acidification, a
process preceding iron release, we treated the cells with bafilomycin, a specific inhibitor of
the vacuolar type H(+)-ATPase (Yoshimori et al., 1991). Treatment with bafilomycin
reduced the uptake of 59Fe-Tf to a similar extent in both control and Snx3-silenced cells
(Figures 4A and S3C). In the presence of bafilomycin, the Snx3-silenced cells still
maintained a lower uptake of 59Fe-Tf than the control cells (Figure 4A), suggesting that this
reduced iron uptake is not due to pH alteration in endosomes. In addition, this reduced Tf
uptake is not a consequence of decreased accessibility of its receptor, as evidenced by the
normal levels of Tfrc on the surface of Snx3-silenced cells (Figure 4B).
The reduction in the uptake of Tf iron, despite the presence of the receptor Tfrc, suggests
that the Snx3-silenced cells may have defective vesicular trafficking of the Tf-Tfrc complex.
To characterize the defect in the Tf cycle, we incubated the stable MEL cells with Tf-Alexa
488 and analyzed the subcellular distribution of Tf. We found that in Snx3-silenced cells,
the Alexa-labeled Tf accumulated as large intracellular clusters (Figures 4C, 4D, S3D, and
S3E). The clustered Tf signal colocalized with Tfrc as well as Rab5, a marker for the early
endosomal compartment, indicating that the internalized Tf complex is trapped in the
enlarged early endosomal compartments. In the majority of control cells, no clustered
pattern is observed, indicating constant recycling and clearance of the internalized Tf. These
results suggest that the endosomal trafficking of Tf is impaired in Snx3-silenced cells.
To quantify the defect on the sorting and recycling of Tf, we pulsed-labeled the Snx3-
silenced cells with holo-Tf conjugated with fluorescent Alexa 647, and measured the
kinetics of Tf release following the chase with unlabeled Tf. As shown in Figure 4E,
silencing of Snx3 significantly delayed the recycling of internalized Tf. The t1/2 of Tf
release was >30% longer in the Snx3-silenced cells (9.99 ± 0.34 min and 10.08 ± 0.68 min
for the two shRNA clones) than that in the control clone (7.36 ± 0.4 min). These data
indicate that Snx3 is required for the efficient recycling of Tf-Tfrc complex.
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Silencing of Snx3 reduces the turnover rate of Tfrc
Previously, it was observed that suppression of Tfrc recycling accelerated its degradation by
lysosomes in HeLa cells (Traer et al., 2007). Is the Tfrc accumulated in the early endosomes
of Snx3-silenced cells more likely to be degraded? Is Tfrc expression altered in response to
potential changes in its stability as well as cellular iron deficiency in these cells? To address
these questions, we rigorously examined the steady state level, the synthesis rate, and the
degradation rate of Tfrc protein. Results from immunoblotting analysis revealed a moderate
decrease in Tfrc protein abundance in Snx3-silenced clones, suggesting reduced Tfrc
expression (Figures 5A and 5B). Consistent with this observation, the silencing of Snx3
produced a severe reduction of ~3.8 fold in Tfrc mRNA levels in MEL cells (Figure 5C).
The Tfrc mRNA has five iron regulatory elements (IREs) in its 3′ untranslated region
(UTR), and iron deficiency would in general induce its expression by stabilizing the mRNA
by iron regulatory proteins (IRPs) (Casey et al., 1988). In erythroid cells, however, the Tfrc
expression is regulated by mechanisms that are independent of the IRE/IRP system( Chan et
al., 1994; Ponka and Lok, 1999; Schranzhofer et al., 2006). To confirm the lack of iron-
dependent regulation of Tfrc expression in differentiated MEL cells, we treated the wild
type cells with the iron chelator desferrioxamine (DFO) and analyzed the Tfrc expression by
qRT-PCR. The results indicated that iron depletion increased the level of Tfrc mRNA in
undifferentiated MEL cells, but not in differentiated erythroid-like MEL cells (Figure S4).
This evidence supports the notion that the reduction in Tfrc mRNA in Snx3-silencing cells is
mediated through an IRE/IRP-independent mechanism.
To rigorously analyze the effect of Snx3 deficiency on the synthesis and stability of Tfrc
protein, we metabolically labeled the cells with L-[35S]methionine and L-[35S]cysteine and
examined the protein turnover rates of Tfrc. Consistent with the qRT-PCR data, the stable
Snx3 silenced clonessynthesized Tfrc protein at a ~3.5fold lower rate than the control
(Figures 5Dand 5 E). In addition, the rate of Tfrc degradation following pulse-chase was
also lower (~3.1 fold) in Snx3-silenced clones (Figures 5D and 5E), suggesting that the Tf
complex accumulated in the endosomal compartments is not missorted into lysosomes for
degradation. In contrast to Tfrc, the steady state levels of other proteins that traffic through
the endosomal compartments, such as Snap23 and Lamp1 (Cook et al., 2004; Valdez et al.,
1999), were not significantly altered (Figures S5A and S5B). These results indicate that the
abnormal expression and stability of Tfrc is not due to a global delay in the progression to
lysosomes. Thus, Snx3-silenced cells have a reduced turnover rate as well as defective
trafficking of Tfrc.
Snx3 interacts with Tfrc in an oligomeric complex
Our findings suggest that when Tf-Tfrc complex transits through the early endosomes, it
may transiently associate with Snx3 in order to be sorted to the recycling endosomes. To test
this hypothesis, we transiently co-expressed Snx3 and FLAG-tagged Tfrc in heterologous
HEK293 cells and affinity purified the protein complex associated with Tfrc using anti-
FLAG beads. The known mitochondrial transmembrane protein Abcb10 was used as a
control for nonspecific interactions between membrane-associated proteins (Chen et al.,
2009; Shirihai et al., 2000). We detected a significantly higher quantity of Snx3 that was
associated with Tfrc than Abcb10 (Figure 6A). To exclude the potential artifact from ectopic
over-expression studies, we performed the pull-down assays in MEL cells that stably
express either Tfrc-FLAG or Abcb10-FLAG driven by the promoter of eukaryotic
translation elongation factor 1α. Under both undifferentiated and DMSO-induced
conditions, endogenous Snx3 specifically interacted with Tfrc (Figure 6B). In addition, Tfrc,
but not Abcb10, was able to pull down Vps35, the cargo-selective component of the
retromer complex. These data therefore demonstrate that Snx3, together with other retromer
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complex components, regulates the endocytic recycling of Tf-Tfrc complex through physical
interaction with Tfrc.
The heme defects due to Snx3 deficiency are rescued by supplementation with non-Tf
bound iron-chelates
To demonstrate the functional specificity of Tfr-dependent iron uptake pathway affected by
Snx3 deficiency, we tested whether supplementation of non-Tf bound iron-chelates could
complement the hemoglobinization defect in Snx3-silenced cells and zebrafish embryos. It
has been previously reported that iron conjugated with salicylaldehyde isonicotinoyl
hydrazone (Fe-SIH) could be taken up by erythroid cells through a Tfrc-independent
pathway (Garrick et al., 1991; Zhang et al., 2006). Supplementation of ferric citrate (Fe-
citrate), Fe-SIH, or a related chemically-defined iron supplement (Sigma-Aldrich I3153, Fe-
chelate mixture, containing EDTA, citrate, and salicylic acid derivative) all increased the
population of o-dianisidine positive cells by 2–5 fold in Snx3-silenced MEL clones (Figures
7A and S6). The rescue effects of these iron compounds were further confirmed in zebrafish
in vivo. Here we took advantage of the observation that snx3 morphant embryos have
reduced number of erythrocytes at 72 hpf, an outcome of apoptosis induced by severe iron
deficiency, and rigorously quantified the effects of the non-Tf iron-chelate supplements by
flow cytometry (Figure 2D). We found that these iron-chelate supplements increased the
number of erythrocytes, as indicated by GFP fluorescence, in snx3-silenced Tg(globin-
LCR:eGFP) embryos (Figure 7B). The gene encoding the mitochondrial iron importer
mitoferrin-1 (slc25a37), mfrn1, was used as a control since its knockdown was known to
induce hypochromic anemia due to iron deficiency (Shaw et al., 2006). The chemical
complementation with the iron-chelate compounds reinforces our proposed model that Snx3
specifically regulates Tfrc-dependent iron assimilation in red cell development.
DISCUSSION
Our study demonstrates that Snx3 regulates endocytic recycling of Tfrc, and thus plays a
critical role in cellular iron homeostasis and erythropoiesis in vertebrates (Figure 7C). The
yeast homolog of Snx3, Grd19p, has been shown to mediate the endocytic recycling of
Fet3p-Ftr1p, a yeast-specific reductive iron transporter system, through direct interaction
with Ftr1p (Strochlic et al., 2008; Strochlic et al., 2007). Taken together, Snx3 may play a
regulatory role in iron homeostasis across multiple eukaryotic phyla.
Snx3 is highly expressed in hematopoietic tissues of zebrafish and mouse. To account for
the enrichment of Snx3 mRNA in blood islands and the increase in Snx3 protein expression
in differentiating MEL cells, we searched GATA-1 and EKLF/KLF1 ChIP-seq databases to
determine if Snx3 could be regulated by key transcriptional regulators of erythropoiesis. As
predicted, the Snx3 gene is bound by EKLF/KLF1 (Tallack et al., 2010) and GATA-1 (Yu et
al., 2009) in vivo. In addition to the regulation at the transcriptional level, the mouse Snx3
also has a predicted IRE-like structure in the 3′ UTR of its mRNA (5′-
CGCUGUGUCCGUGUGCACACUG-3′) (Campillos et al., 2010). The abundance of Snx3
mRNA, however, showed no changes in response to either iron depletion with
desferrioxamine or iron overload with 200 μM ferric citrate (Figure S7), suggesting that the
putative IRE is not functional. Furthermore, the putative 3’UTR IRE is not conserved in
other vertebrate Snx3 orthologs.
Snx3 has been shown to interact with Vps35, the cargo-selective component of retromer
(Vardarajan et al., 2012; Zhang et al., 2011). In addition, a proteomic study in yeast detected
interactions between Grd19p and Sec15p (Vollert and Uetz, 2004), whose ortholog in
mammals was shown to control the sorting of Tf-Tfrc complexes in recycling endosomes
(Lim et al., 2005; White et al., 2005; Zhang et al., 2006). Here we found that Tfrc physically
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interacts with both Snx3 and Vps35. These data indicate that Snx3 and the Vps proteins may
constitute a non-classical retromer complex that interacts with Tf-Tfrc oligomers in early
endosomes and deliver them to Sec15l1 in recycling endosomes (Figure 7C).
The important role of Snx3 in Tf trafficking was independently validated by studies in
mammalian hematopoietic cells. Silencing of Snx3 reduced the rate of Tf recycling and the
uptake of Tf-bound iron (Figures 4A and 4E). In Snx3-silenced cells, the internalized Tf
accumulated as large intracellular clusters in the early endosomes (Figures 4C and 4D). This
defective trafficking may be responsible for the reduced turnover rate of Tfrc protein (Figure
5). Interestingly, although the Snx3-silenced cells had an increased level of Tf-Tfrc
complexes in the enlarged early endosomes and a reduced amount of total cellular Tfrc, we
did not find any reduction in the cell surface-bound Tfrc (Figure 4B). The normal level of
Tfrc on the cell surface may be maintained by such factors as the extended stability of Tfrc
and the likely reduced internalization rate of Tfrc. The reduced internalization
accompanying reduced recycling has been observed for Sec15l1, which also plays a
regulatory role in the Tf cycle (Zhang et al., 2006). Our data further suggest that the
defective Tf trafficking due to Snx3 deficiency may have altered the distribution of Tfrc
between the early and the recycling endosomes, whereas the Tfrc abundance on the cell
surface may not be as directly impacted. Further investigation may be needed to test these
possibilities and to fully characterize the steady-state equilibrium of Tfrc in the Snx3-
silenced cells.
In nonerythroid cells, the interaction of Snx3 with Tfrc may be functionally substituted by
other receptors, implying a broader role for Snx3 in retromer-mediated vesicular recycling.
Two independent reports have shown that Snx3 mediates the retrograde transport of the Wnt
sorting receptor Wntless and is required for Wnt secretion in flies and worms (Harterink et
al., 2011; Zhang et al., 2011). The involvement of Snx3 in two discrete cellular pathways
suggests that it regulates the endosomal sorting of a repertoire of cargo receptors including
Tfrc and Wntless, and thus plays a fundamental role in intracellular vesicle trafficking.
The fundamental role of Snx3 in endosomal sorting was further attested by its involvement
in the retrograde trafficking of amyloid precursor protein (APP) (Vardarajan et al., 2012).
Through analyzing a genome-wide association study (GWAS) dataset, this study identified
significant association between the single nucleotide polymorphisms (SNPs) in SNX3 and
Alzheimer disease. Results from this study further indicated that SNX3 and VPS proteins
form a retromer complex that mediates the retrieval of APP from endosomes to Golgi, thus
preventing the generation of the neurotoxic amyloid β peptide. In addition, another research
group located a SNX3 gene disruption in a patient with microcephaly, microphthalmia,
ectrodactyly, and prognathism (MMEP) (Vervoort et al., 2002). However, no mutations in
the coding region of SNX3 were found in five additional patients with MMEP, suggesting
that the defect in SNX3 may not be responsible for the MMEP phenotype (Kumar et al.,
2007).
Given the profound anemic phenotype in snx3-silenced zebrafish embryos, it is also likely
that mutations in SNX3 may lead to hematological disorders in humans. We therefore
searched the NHGRI human GWAS databases (Hindorff et al., 2009), but we were not able
to find a significant association between SNX3 SNPs and the hematologic traits (Ganesh et
al., 2009; Soranzo et al., 2009). Two SNPs that are associated with hematologic traits
located in the same cytoband as SNX3, rs11966072 and rs4947019, are located at a
considerable distance (>1 Mb) from the SNX3 locus, making them unlikely disease causing
candidates in SNX3. Further genetic and sequencing studies on anemic patients with
undefined etiologies may help to reveal the potential connection between SNX3 and
hematological disorders. Thus, the identification of Snx3, as an essential co-regulatory
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protein that regulates Tf-mediated iron delivery for heme synthesis, provides a genetic tool
for exploring erythropoiesis and human disorders of iron metabolism, such as the
hypochromic anemias.
EXPERIMENTAL PROCEDURES
Zebrafish Experiments
All zebrafish experiments were performed in compliance with the Institutional Animal Care
and Use Committee (IACUC) regulations at Boston Children’s Hospital. AB, cloche
(clom39) (Stainier et al., 1995), dino (dintm84) (Hammerschmidt et al., 1996), and Tg(globin-
LCR:eGFP) (Ganis et al., 2012) transgenic lines were used in this study. Whole-mount in
situ hybridization was carried out as previously described (Amigo et al., 2011). An ATG-
blocking and a splice-blocking anti-sense morpholinos for snx3 were obtained from Gene
Tools (Supplemental Information), and each MO was individually injected into one-cell
stage zebrafish embryos. The embryos were harvested at 24~72 hpf for WISH and 48~72
hpf for o-dianisidine staining, following the protocols described previously (Shaw et al.,
2006). Flow cytometry on the Tg(globin LCR:eGFP) embryos was preformed as previously
described (Cooney et al., 2013).
Knock down of Snx3 in mouse cells
shRNA constructs (Supplemental Information) were purchased from Sigma-Aldrich. Stable
Snx3-silenced MEL clones were generated by electroporation, followed by selection with
puromycin. Snx3 was silenced in MPFL cells by infection with retroviruses containing
shRNAs for Snx3 (Hattangadi et al., 2010). The knockdown efficiency was examined by
immunoblotting analysis. The hemoglobin in stable MEL cells was stained with o-
dianisidine, and the hemoglobin content in MPFL was measured with Drabkin’s reagent
(Hattangadi et al., 2010).
Transferrin uptake and immunofluorescence assays
Stable Snx3-silenced MEL clones were labeled with 59Fe-transferrin as previously described
(Zhang et al., 2006). 59FeCl3 (specific activity: 42.59 mCi/mg) was obtained from
PerkinElmer. The MEL cells were also incubated with transferrin-Alexa 488 followed by
immunofluorescence studies using antibodies against Tfrc and Rab5.
Metabolic [35S]-labeling
Stable Snx3-silenced MEL cells were labeled with L-[35S]methionine and L-[35S]cysteine
(PerkinElmer, >1,000 Ci/mmol specific activity) following a protocol described previously
(Paradkar et al., 2009). The abundance of [35S]-labeled Tfrc was examined at different time
during both pulse and pulse-chase phases.
Tfrc pull-down assays
The FLAG-tagged Tfrc and Abcb10 constructs were generated using the same strategy as
previously reported (Chen et al., 2009). MEL clones stably expressing Tfrc-FLAG or
Abcb10-FLAG were generated by electroporation followed by puromycin selection. Cell
lysates from the stable MEL cells or HEK293 cells transiently transfected with Snx3
plasmids in combination with Tfrc-FLAG or Abcb10-FLAG were subjected to FLAG pull-
down assays using ANTI-FLAG M2 Affinity Gel (Chen et al., 2009).
Iron supplementation experiments
A chemically defined iron supplement (Sigma-Aldrich, I3153; EC #231-791-2), 20 μM Fe-
SIH, or 20 μM Fe-citrate was supplemented to MEL cells during the erythroid-like
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induction. The embryos from Tg(globin-LCR:eGFP) transgenic zebrafish were injected with
morpholinos against snx3 or the positive control mfrn1. These zebrafish embryos were
treated with the chemically defined iron supplement or 10 μM Fe-SIH at 30 hpf, and were
analyzed for the percentage of erythrocytes based on GFP fluorescence by flow cytometry at
72 hpf.
Statistical analysis
All data are presented as mean ± standard error of the mean (SEM). Statistical significance
was tested using one-way ANOVA followed by the Tukey-Kramer Multiple Comparisons
Test in GraphPad INSTAT version 3.01 (GraphPad, San Diego, CA, USA). A P value of <
0.05 was considered as statistically significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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HIGHLIGHTS
1. Snx3 is highly expressed in vertebrate hematopoietic tissues.
2. Silencing of Snx3 results in anemia and hemoglobin defects in vertebrates.
3. Snx3 and Vps35 physically interact with Tfrc.
4. Snx3 is required for endosomal recycling of Tf-Tfrc complex.
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Figure 1. Snx3 is highly expressed in erythroid tissues
(A) Snx3 is upregulated during the erythroid maturation of mouse fetal liver cells. The
schematic heat map shows the results of an mRNA sequencing experiment on Snx3 and
control genes in the five erythroid sub-populations sorted from mouse fetal liver at E12–16
(Wong et al., 2011). The arrow on the top indicates the process of red cell maturation with
R1 population representing primitive progenitor cells and proerythroblasts and R5
population representing late orthochromatophilic erythroblasts and reticulocytes (Zhang et
al., 2003). (B) Snx3 transcripts are enriched in mouse hematopoietic tissues. In situ
hybridization revealed robust expression of Snx3 in the yolk sac (YS) blood islands at E8.5
and fetal liver (FL) at E12.5 and E15.5. At E15.5, Snx3 is also expressed in heart (H), lung
(L), kidney (K), and gut (G). (C) Snx3 is up-regulated during the chemically induced
differentiation of MEL cells. MEL cells were chemically differentiated with DMSO for the
indicated number of days. The expression of Snx3 and control genes was detected by
western in total cell lysates. (D) Quantification of the immunoblots from panel (C). Error
bars represent SEM from two biological replicates.
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Figure 2. Snx3 is required for heme production in zebrafish embryos
(A) Whole-mount in situ hybridization detects expression of gata1 and snx3 in the blood
island ICM in zebrafish embryos at 24 hpf. The ICM staining is absent in cloche mutants
and is expanded in dino mutants. (B) Western analysis confirms efficient silencing of snx3
by a translation-blocking morpholino (MO1) and a pre-mRNA splice-blocking morpholino
(MO2). The expression of snx4 and α-actin control proteins was unaffected. (C) Injections
of MOs against snx3 result in a profound anemia in zebrafish embryos at both 48- and 72-
hpf. (D) Knockdown of snx3 in Tg(globin-LCR:eGFP) transgenic zebrafish leads to reduced
number of erythrocytes at 72 hpf, but not at 48 hpf. Error bars represent SEM from three
biological replicates. *P < 0.001 compared with the control morpholino.
Chen et al. Page 16
Cell Metab. Author manuscript; available in PMC 2014 March 05.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 3. Knockdown of snx3 results in hemoglobinization defects in mouse hematopoietic cells
(A) Western analysis confirms the silencing of Snx3 by shRNA in mouse primary fetal liver
cells. (B) Silencing of Snx3 by shRNA reduces the hemoglobin content in mouse primary
fetal liver cells. Error bars represent SEM from two independent experiments. *P < 0.05
compared with the control. (C) Snx3 expression is inhibited in stable MEL clones
expressing two shRNA hairpins under both undifferentiated and chemical differentiated
conditions. (D) Knockdown of Snx3 impairs hemoglobin production in MEL cells during
differentiation. Error bars represent SEM from three replicates. *P < 0.001 compared with
the control shRNA clone. (E) Representative images of cytospin MEL cells stained with o-
dianisidine for hemoglobin from panel (D).
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Figure 4. Snx3 is essential for the uptake of Tf bound iron in differentiated MEL cells
(A) Snx3-silenced MEL cells exhibit reduced uptake of Tf bound iron. The cellular uptake
of 59Fe-Tf and the incorporation of imported 59Fe into heme are both affected. Treatment
with bafilomycin, an inhibitor of the vacuolar type H(+)-ATPase, reduced the uptake
of 59Fe-Tf to a similar extent in the control and Snx3-silenced cells. Error bars represent
SEM from three replicates. *P < 0.05 compared with the control shRNA clone; †P < 0.01
compared with the untreated cells. (B) The levels of surface-bound Tfrc are not affected in
Snx3-silenced MEL clones. FITC-labeled anti-CD71 antibody was incubated with the MEL
cells and the fluorescence was measured by flow cytometry. Error bars represent SEM from
three replicates. (C and D) Internalized Tf-Tfrc complex accumulates as large intracellular
clusters in early endosomal compartments (arrows) in Snx3-silenced MEL clones. Scale
bars, 10 μm. (E) Pulse-chase study using Tf-Alexa 647 reveals delayed release of
internalized Tf in Snx3-silenced cells. The mean fluorescence intensities (MFI) of
intracellular Tf-Alexa 647 are presented as percent signal relative to time 0. Error bars
represent SEM from two replicates within a single experiment. *P < 0.01 between both
Snx3-silenced clones and the control shRNA clone.
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Figure 5. Silencing of Snx3 reduced the rates of both synthesis and degradation of Tfrc
(A) The steady-state level of total Tfrc protein is moderately reduced in Snx3-silenced MEL
cells. (B) Quantification of the immunoblots from panel (A). Error bars represent SEM from
two biological replicates. *P < 0.05 compared with the control shRNA clone. (C) qRT-PCR
analysis shows reduced amounts of Tfrc mRNA in Snx3-silenced MEL cells. Error bars
represent SEM from two independent experiments. *P < 0.05 compared with the control
shRNA clone. (D) 35S pulse-chase assays demonstrate lower rates of both synthesis and
degradation of Tfrc protein. (E) Quantification of autoradiographic bands of 35S-Tfrc from
panel (D). The experiments were performed in one replicate. Linear regression models were
fitted to the data, and the slopes were indicated as +k or −k for the rates of synthesis or
degradation, respectively.
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Figure 6. Physical interactions among Snx3, Vps35, and Tfrc
(A) Protein pull-down assays in a heterologous system indicate interactions between Snx3
and Tfrc. Cell lysates from HEK293 cells ectopically expressing Tfrc-FLAG or the control
Abcb10-FLAG combined with Snx3 were purified with anti-FLAG beads followed by
western analysis. The western blots of whole cell lysates (protein input) and the binding
fractions (FLAG elution, 30×) are presented. (B) Tfrc interacts with both Snx3 and Vps35 in
MEL cells. MEL cells stably expressing Tfrc-FLAG or the control Abcb10-FLAG were
subjected to the protein pull-down assays. The endogenous Snx3 and Vps35 copurified with
Tfrc-FLAG, but not with Abcb10-FLAG.
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Figure 7. Complementation of the hemoglobinization defects with non-Tf bound iron
supplements
(A) Fe-SIH, ferric citrate, and a chemically defined iron supplement increase the
hemoglobin production in Snx3-silenced MEL cells after chemically induced differentiation.
Error bars represent SEM from three independent experiments. *P < 0.001 compared with
the control clone; †P < 0.05 compared with the DMSO control within the group. (B) Fe-SIH
and a chemically defined iron supplement restore the number of erythrocytes in snx3
morphant zebrafish embryos at 72 hpf. Mitoferrin1 (mfrn) is used as a positive control for
iron rescue. Error bars represent SEM from two independent experiments. *P < 0.001
compared with the control morpholino; †P < 0.05 compared with the untreated embryos. (C)
The proposed role of Snx3 in Tf cycle. In early endosomes, Snx3, along with Vps35,
transiently interacts with and sorts the Tf-Tfrc complex into recycling endosomes. Sec15l1
regulates the trafficking of Tf-Tfrc complex from recycling endosomes to cell surface. ISCs,
iron sulfur clusters.
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